Patent intelligence · US
US 11364202
Solid forms of cannabidiol and uses thereof
Solid forms of cannabidiol and uses thereof
Patent details — US 11364202
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 21, 2022
- Expiration
- Jun 16, 2042
- Applicant
- Artelo Biosciences, Inc.
- Claims
- 14
- CPC classes
- A61K, A61K31/05, A61K31/352, A61K31/658
Quick answer
US 11364202 (Solid forms of cannabidiol and uses thereof) is held by Artelo Biosciences, Inc.. Status: granted. Granted Jun 21, 2022. Expires Jun 16, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Artelo Biosciences, Inc.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K31/05, A61K31/352, A61K31/658, A61K47/183, A61K47/545
More from Artelo Biosciences, Inc.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 11364202?
US 11364202 (Solid forms of cannabidiol and uses thereof) is held by Artelo Biosciences, Inc.. Status: granted. Granted Jun 21, 2022. Expires Jun 16, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11364202?
Artelo Biosciences, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does US 11364202 expire?
Our index shows an expiration date of Jun 16, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.